BioCorRx Inc.
BICXOTCHealthcare● Active
$0.38
+$0.00(+0.00%)
Market Cap$7933712
P/E Ratio—
52W High$1.28
52W Low$0.2
BioCorRx Inc. (BICX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BICX · as of 2026-06-13
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.80M | $0.01M | $0.09M | $0.21M | $0.05M |
| Cost of Revenue | $0.11M | $0.00M | $0.04M | $0.02M | $0.01M |
| Gross Profit | $0.69M | $0.01M | $0.05M | $0.20M | $0.04M |
| Gross Margin %(computed) | 86.72% | 78.25% | 59.64% | 92.85% | 87.82% |
| Operating Expenses | |||||
| R&D Expenses | $1.77M | $1.48M | $0.89M | $1.46M | $1.61M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $5.52M | $5.13M | $3.84M | $3.11M | $4.58M |
| Operating Income | ($4.83M) | ($5.12M) | ($3.79M) | ($2.91M) | ($4.53M) |
| Operating Margin %(computed) | -606.04% | — | — | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.86M | $1.53M | $0.89M | $1.09M | $0.57M |
| Income Before Tax | ($3.51M) | ($5.21M) | ($3.77M) | ($4.38M) | ($5.21M) |
| Income Tax Expense | ($0.07M) | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($3.44M) | ($5.11M) | ($3.77M) | ($4.37M) | ($5.80M) |
| Net Margin %(computed) | -431.50% | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.19 | $-0.49 | $-0.45 | $-0.61 | $-0.89 |
| Wtd Avg Shares | 18.49M | 10.46M | 8.34M | 7.20M | 6.49M |
| EBITDA | ($2.56M) | ($3.59M) | ($2.68M) | ($3.15M) | ($4.48M) |
| EBITDA Margin %(computed) | -321.50% | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-13 · USD · M
Explore more BioCorRx Inc. data
About BioCorRx Inc. (BICX) Income Statement
BioCorRx Inc. (BICX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BICX reported revenue of $0.00B, gross profit of $0.00B (gross margin 86.72%), and net income of ($0.00B) — a net profit margin of -431.50%.
Frequently asked questions
BICX · 4 questionsBioCorRx Inc. (BICX) reported revenue of $0.00B for 2025, up 10301.1% year-over-year.
BICX revenueBICX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-13